TAGLN Human Pre-designed siRNA Set A contains three designed siRNAs for TAGLN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAGLN2 Human Pre-designed siRNA Set A contains three designed siRNAs for TAGLN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAGLN3 Human Pre-designed siRNA Set A contains three designed siRNAs for TAGLN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PF-07104091 hydrate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively. PF-07104091 hydrate has anti-tumor activity for cyclin E1-amplified cancers. (patent WO2020157652A2).

PF-07104091 hydrate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively. PF-07104091 hydrate has anti-tumor activity for cyclin E1-amplified cancers. (patent WO2020157652A2).

PF-07104091 hydrate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively. PF-07104091 hydrate has anti-tumor activity for cyclin E1-amplified cancers. (patent WO2020157652A2).

PF-07104091 hydrate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively. PF-07104091 hydrate has anti-tumor activity for cyclin E1-amplified cancers. (patent WO2020157652A2).

PF-07104091 hydrate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively. PF-07104091 hydrate has anti-tumor activity for cyclin E1-amplified cancers. (patent WO2020157652A2).

PF-07104091 hydrate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively. PF-07104091 hydrate has anti-tumor activity for cyclin E1-amplified cancers. (patent WO2020157652A2).

TAK1-IN-5 (Compound 26) is an inhibitor of the transforming growth factor-β activated kinase (TAK1) with an IC50 value of 55 nM. TAK1-IN-5 can inhibit the growth of MPC-11 and H929 cells with a GI50 lower than 30 nM. TAK1-IN-5 can be used in the study of multiple myeloma [1].

TAL1 Human Pre-designed siRNA Set A contains three designed siRNAs for TAL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAL2 Human Pre-designed siRNA Set A contains three designed siRNAs for TAL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Talaroderxine D (compound 4) has biofilm inhibitory effect. Talaroderxine D shows antimicrobial activities against Bacillus subtilis and Staphylococcus aureus with MIC values of 2.1 and 8.3 μg/mL[1].

Talastine is a potent H1-antihistamine. Talastine can induce allergic exanthema[1][2].

TALDO1 Human Pre-designed siRNA Set A contains three designed siRNAs for TALDO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAM557 TFA is a cytotoxic tubulysin compounds, which is modified to be used for conjugation to transport vehicles that are targeting molecules, such as proteins, peptides, small molecules or polymeric carriers which can carry a targeting principle[1].

TAM557 TFA is a cytotoxic tubulysin compounds, which is modified to be used for conjugation to transport vehicles that are targeting molecules, such as proteins, peptides, small molecules or polymeric carriers which can carry a targeting principle[1].

TAMALIN Human Pre-designed siRNA Set A contains three designed siRNAs for TAMALIN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tamarixetin 3-O-β-d-apiofuranosyl-(1 → 2)-β-d-galactopyranoside (compound 4) is an inhibitor of collagenase and elastase with potential anti-inflammatory activity. Tamarixetin 3-O-β-d-apiofuranosyl-(1 → 2)-β-d-galactopyranoside can be isolated from the methanol extract of the Balkan endemic species Astragalus thracicus Griseb.[3][1].

TAMM41 Human Pre-designed siRNA Set A contains three designed siRNAs for TAMM41 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tamoxifen-d3 hydrochloride is deuterated labeled Tamoxifen (Citrate) (HY-13757). Tamoxifen Citrate (ICI 46474) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells[1][2][3].Tamoxifen Citrate is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone […]

TAMRA amine, 5-isomer is an isomer of TAMRA, a xanthene dye with orange emission.

TAMRA azide, 6-isomer is an isomer of TAMRA, a xanthene dye with orange emission.

TANC1 Human Pre-designed siRNA Set A contains three designed siRNAs for TANC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TANC2 Human Pre-designed siRNA Set A contains three designed siRNAs for TANC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TANGO2 Human Pre-designed siRNA Set A contains three designed siRNAs for TANGO2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TANK Human Pre-designed siRNA Set A contains three designed siRNAs for TANK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAOK1 Human Pre-designed siRNA Set A contains three designed siRNAs for TAOK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAOK2 Human Pre-designed siRNA Set A contains three designed siRNAs for TAOK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAOK3 Human Pre-designed siRNA Set A contains three designed siRNAs for TAOK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAP2 Human Pre-designed siRNA Set A contains three designed siRNAs for TAP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAPBP Human Pre-designed siRNA Set A contains three designed siRNAs for TAPBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAPBPL Human Pre-designed siRNA Set A contains three designed siRNAs for TAPBPL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TAPS sodium is a biological buffer that protects the structural integrity of lysozyme bacteria and prevents them from thermal denaturation at high temperatures. A pKa of 8.1 for TAPS results in half-maximal connexin channel activity[1][2].

TAPT1 Human Pre-designed siRNA Set A contains three designed siRNAs for TAPT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TARBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TARBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TARBP2 Human Pre-designed siRNA Set A contains three designed siRNAs for TARBP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TARDBP Human Pre-designed siRNA Set A contains three designed siRNAs for TARDBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Targocil-II (Compound 2) is an ABC transporter inhibitor with a IC50 value of 137 nM. Targocil-II prevents ATP hydrolysis by binding to allosteric sites of the TM domain. Targocil-II has (antibacterial) activity[1].

Targocil-II (Compound 2) is an ABC transporter inhibitor with a IC50 value of 137 nM. Targocil-II prevents ATP hydrolysis by binding to allosteric sites of the TM domain. Targocil-II has (antibacterial) activity[1].

Targocil-II (Compound 2) is an ABC transporter inhibitor with a IC50 value of 137 nM. Targocil-II prevents ATP hydrolysis by binding to allosteric sites of the TM domain. Targocil-II has (antibacterial) activity[1].

Targocil-II (Compound 2) is an ABC transporter inhibitor with a IC50 value of 137 nM. Targocil-II prevents ATP hydrolysis by binding to allosteric sites of the TM domain. Targocil-II has (antibacterial) activity[1].

TARM1 Human Pre-designed siRNA Set A contains three designed siRNAs for TARM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TARS2 Human Pre-designed siRNA Set A contains three designed siRNAs for TARS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.